Open AccessThe role of urotensin II and atherosclerotic risk factors in patients with slow coronary flow
Author(s) -
Ömer Şatıroğlu,
Murtaza Emre Durakoğlugil,
Mustafa Çetın,
Yüksel Çiçek,
Turan Erdoğan,
Hakan Duman
Publication year - 2016
Publication title -
interventional medicine and applied science/interventional medicine and applied science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.195
H-Index - 14
eISSN - 2061-5094
pISSN - 2061-1617
DOI - 10.1556/1646.8.2016.4.1
Subject(s) - urotensin ii , medicine , cardiology , coronary artery disease , pathogenesis , coronary arteries , artery , vasodilation , blood flow , endocrinology , receptor
Slow coronary flow (SCF) is an angiographic finding characterized with delayed opacification of epicardial coronary arteries without obstructive coronary disease. Urotensin II (UII) is an important vascular peptide, which has an important role in hypertension, coronary artery disease, and vascular remodeling in addition to potent vasoconstrictor effect.